Rapid progression of mixed neuroendocrine carcinoma-acinar adenocarcinoma of the prostate: A case report.

about

Rapid progression of mixed neuroendocrine carcinoma-acinar adenocarcinoma of the prostate: A case report.

Item

http://www.wikidata.org/entity/Q42413411

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Rapid progression of mixed neu ...... f the prostate: A case report.

@en

Rapid progression of mixed neu ...... f the prostate: A case report.

@nl

type

Item

label

Rapid progression of mixed neu ...... f the prostate: A case report.

@en

Rapid progression of mixed neu ...... f the prostate: A case report.

@nl

prefLabel

Rapid progression of mixed neu ...... f the prostate: A case report.

@en

Rapid progression of mixed neu ...... f the prostate: A case report.

@nl

P1476

Rapid progression of mixed neu ...... f the prostate: A case report.

@en

P2093

Jingchao Wei

http://www.w3.org/2001/XMLSchema#string

Leye He

http://www.w3.org/2001/XMLSchema#string

Liuxun Li

http://www.w3.org/2001/XMLSchema#string

Wensu Wei

http://www.w3.org/2001/XMLSchema#string

Xiaoping Zheng

http://www.w3.org/2001/XMLSchema#string

Zhi Long

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroendocrine differentiation in prostate adenocarcinoma

Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review.

Unusual and underappreciated: small cell carcinoma of the prostate.

A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008.

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.

Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes.

Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis.

The evolution of prostate cancer therapy: targeting the androgen receptor

The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research.

Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

P304

1019-1022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4737

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27446387

http://www.w3.org/2001/XMLSchema#string

P932

4950814

http://www.w3.org/2001/XMLSchema#string